DNTH
Dianthus Therapeutics, Inc. · Healthcare
EVP, Head of R&D Simrat Randhawa sold $2.5M of Dianthus Therapeutics, Inc.
Sold$2,460,690
$106.41Price
23,124Shares
−85%Stake
What DNTH did after the filing
- The stock from Fri, Sep 4 open, $107.06
- −17.6%
- S&P 500, same days
- −0.3%
19 of 30 trading days so far, to the Oct 2 close.
Traded Tue, Sep 1. Filed Thu, Sep 3, 4:30 PM ET, after the close. Returns use the Sep 4 open and the Oct 2 close. Not investment advice.